NCT03280641View on ClinicalTrials.gov

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

CompletedOBSERVATIONAL
Enrollment

1,194

Participants

Timeline

Start Date

August 9, 2015

Primary Completion Date

July 30, 2017

Study Completion Date

September 1, 2017

Conditions
Atrial FibrillationStrokes Thrombotic
Interventions
DRUG

Dabigatran Etexilate 110mg

Dabigatran Etexilate 110mg, BID

DRUG

Warfarin Sodium

Target INR:1.6-3.0

Trial Locations (1)

430000

WAHH, Wuhan

All Listed Sponsors
lead

Wuhan Asia Heart Hospital

OTHER

NCT03280641 - D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy | Biotech Hunter | Biotech Hunter